Skip to content
★ Sign in to follow
PJ

Phillip John Brancazio

Executive
Total declarations
6
Company
1
▲ Purchases (3 ops.)
€6,879
▼ Sales (0 ops.)
—

Latest filing published 04 May 2011 for HAEMONETICS CORP, €2,114.

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
3
Positive at T+90
33%
Median T+90
-3.5%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 04 May 2011 · 5668 days ago · €2,114
    +6.2%
    Entry US$33.63 · Close at T+365 US$35.72
  • Filed 08 Nov 2010 · 5845 days ago · €2,427
    -0.7%
    Entry US$29.39 · Close at T+365 US$29.17
  • Filed 04 May 2010 · 6033 days ago · €2,337
    +19.6%
    Entry US$28.11 · Close at T+365 US$33.63

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Phillip John Brancazio: trading record in brief

Phillip John Brancazio is a declared insider of Haemonetics Corp, with filings sourced from SEC (Form 4). Between 29 July 2009 and 4 May 2011, the trades on record add up to 6 filings.

On the market, this insider has only ever bought: 3 purchases, €6,879 in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 share grants. 2011 to date brings 1 purchase and no sales.

A typical purchase (the median) is worth €2,337. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 33% of cases, with a median move of -3.5%. They describe history only and say nothing certain about the share price ahead.

On 4 May 2011 came the latest disclosure, an open-market purchase for €2,114 in Haemonetics Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Phillip John Brancazio

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total

6 of 6 declarations